TrialJAMA network open2025

Intravenous Immunoglobulin Alone for Coronary Artery Lesion Treatment of Kawasaki Disease: A Randomized Clinical Trial.

Ho-Chang Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.